Nasal Cannabidiol Composition Patent, Frank-Markus Leweke, Apr 9
Summary
Nasal Cannabidiol Composition Patent, Frank-Markus Leweke, Apr 9
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
NASAL CANNABIDIOL COMPOSITIONS
Application US20260097050A1 Kind: A1 Apr 09, 2026
Inventors
Frank-Markus LEWEKE
Abstract
A nasally administered cannabinoid semi-solid or viscous liquid composition; nasal methods for administering the nasal pharmaceutical compositions; methods for manufacturing the nasal pharmaceutical compositions; and nasal methods of treating diseases treatable by the nasal pharmaceutical compositions formulated with a cannabinoid or mixtures thereof.
CPC Classifications
A61K 31/658 A61K 9/0043 A61K 9/06
Filing Date
2025-07-08
Application No.
19263396
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.